CCEP is the second-largest bottling partner in the Coca-Cola system by volume, behind Coca-Cola Femsa, and primarily operates in developed Europe, Australasia, and Southeast Asia... Show more
Coca-Cola Europacific Partners (CCEP) is the world's largest independent Coca-Cola bottler by revenue, operating across more than 30 markets spanning Europe and Asia-Pacific. That scale underpins a structural competitive advantage: exclusive brand access to the Coca-Cola system, dense manufacturing and distribution networks, and deep relationships with major retail and hospitality customers. The company's recent customer wins — including a Marriott International agreement covering more than 600 hotels, Domino's in Australia, and expanded McDonald's listings — illustrate how route-to-market strength continues to convert into incremental revenue.
Medium-term, the story is one of portfolio rebalancing. Growth is increasingly concentrated in energy, zero-sugar, sports, and hydration, categories where CCEP holds strong share momentum, while its core sparkling portfolio remains a cash-generative anchor. The completed acquisition of Coca-Cola Beverages Philippines and the ongoing build-out of Southeast Asian capacity extend the growth runway beyond mature European markets. At the same time, structural risks persist: soft volumes in Germany and France, the transition away from the Beam Suntory alcohol brands, and the regulatory pressure of rising sugar taxes all constrain the pace of expansion.
Several near-term developments could reshape investor sentiment. First, the company's next earnings release is expected around February 2027, when investors will assess whether the 3%–4% revenue growth and roughly 7% operating profit growth guided for fiscal 2026 are being delivered — and whether management's balanced volume, mix, and pricing framework holds into 2027.
Second, the FIFA World Cup 2026 activation represents CCEP's largest-ever commercial program, with more than 500,000 displays and over 47,000 activated outlets. Its effectiveness could meaningfully influence second-half volume trends and set the tone for 2027 brand investment.
Third, capital allocation remains a focal point: a further €1 billion share buyback, running into early 2027, supports earnings per share, while a growing dividend and an investment-grade balance sheet anchor returns. On the analyst front, consensus remains tilted toward Buy, but the profile is mixed. Firms including Wells Fargo, Barclays, Deutsche Bank, and Argus Research maintain Buy ratings, while J.P. Morgan initiated coverage with a Sell, and ING and UBS downgraded to Hold in 2026. Average twelve-month price targets cluster near $108, slightly below recent trading levels, signaling that much of the optimism is already reflected in the share price.
CCEP's trajectory is closely tied to the consumer staples environment. Sticky inflation and elevated interest rates have pressured discretionary spending in parts of Europe, prompting management to lean on affordability and promotional optimization. Higher interest rates cut both ways: they raise the cost of refinancing maturing debt, but they also support the rationale for disciplined capital returns.
Commodity costs — including sweeteners, aluminum, and PET (polyethylene terephthalate, the plastic used in bottles) — remain a margin variable, though roughly 80% of commodities were hedged entering 2026. Regulatory developments are equally important: France and Great Britain have raised soft-drink taxes, which affect both input costs and consumer price sensitivity. Geopolitically, the Middle East conflict introduces uncertainty into cost and demand assumptions. Finally, technology adoption — notably AI-driven analytics and the SAP S/4HANA enterprise system — is emerging as a productivity lever that could support margin expansion even in a low-growth demand backdrop.
The Trend Prediction Engine is an AI-powered forecasting tool designed to help traders assess whether a stock, ETF, or other asset may trend bullish, bearish, or sideways over the coming week or month. It aims to help users identify developing trends, evaluate potential breakouts or reversals, and explore predictions across a broad universe of tradable instruments. The product includes searchable prediction categories, historical context, and alert-oriented functionality to support ongoing market monitoring. For investors tracking CCEP or comparable consumer staples names, it offers a data-driven complement to fundamental analysis.
Looking into 2026 and beyond, CCEP's outlook hinges on three structural themes. The first is cost-structure evolution: a productivity program targeting €350 million–€400 million in savings by 2028, combined with network consolidation and AI-enabled decision-making, is designed to keep operating margins expanding even as revenue growth moderates. The second is market expansion, particularly in the Philippines and Indonesia, where management is investing in new capacity and expects margins to scale toward its ~10% target over time. The third is capital allocation discipline, with management signaling leverage toward the lower end of its 2.5–3.0 times range, sustained buybacks, and a roughly 50% dividend payout ratio.
Offsetting these drivers are genuine competitive and regulatory threats: a challenged consumer backdrop in Germany and France, sugar-tax escalation across Europe, and execution risk in emerging markets. Consensus expectations for 2026 reflect single-digit earnings growth, with analysts forecasting revenue of roughly €21.6 billion and further earnings-per-share expansion in 2027. External twelve-month price targets cluster near $108, implying that analysts see valuation as largely balanced. For investors, the forward-looking question is less about whether CCEP can grow — its record cash generation and category momentum suggest it can — and more about whether productivity savings and Southeast Asian expansion can outpace the macro and regulatory headwinds building across its European core.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, CCEP has been loosely correlated with PEP. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CCEP jumps, then PEP could also see price increases.
| Ticker / NAME | Correlation To CCEP | 1D Price Change % | ||
|---|---|---|---|---|
| CCEP | 100% | +2.08% | ||
| PEP - CCEP | 50% Loosely correlated | +2.24% | ||
| MNST - CCEP | 49% Loosely correlated | +1.44% | ||
| KDP - CCEP | 44% Loosely correlated | +2.73% | ||
| COKE - CCEP | 42% Loosely correlated | -0.39% | ||
| FIZZ - CCEP | 33% Poorly correlated | +3.57% | ||
More | ||||
a bottling company with interests in marketing, production and distribution of Coca-Cola products
Industry BeveragesNonAlcoholic
The 10-day moving average for CCEP crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on CCEP as a result. In 62 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 63%.
The Moving Average Convergence Divergence (MACD) for CCEP just turned positive on September 29, 2026. Looking at past instances where CCEP's MACD turned positive, the stock continued to rise in 23 of 47 cases over the following month. The odds of a continued upward trend are 49%.
CCEP moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.18% 3-day Advance, the price is estimated to grow further. Considering data from situations where CCEP advanced for three days, in 190 of 352 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.
The Aroon Indicator entered an Uptrend today. In 162 of 282 cases where CCEP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.
The 10-day RSI Indicator for CCEP moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In 8 of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at 22%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 32 of 71 cases where CCEP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 45%.
CCEP broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 8 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 71, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. CCEP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.145) is normal, around the industry mean (-4.128). P/E Ratio (26.032) is within average values for comparable stocks, (25.797). Projected Growth (PEG Ratio) (2.715) is also within normal values, averaging (3.732). Dividend Yield (0.033) settles around the average of (0.039) among similar stocks. P/S Ratio (1.873) is also within normal values, averaging (2.785).
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.